CSSP

Circassia Group Plc

CSSPF.US niox.com
0.82
+0.00 (+0.00%)
USD · OTCGREY
52-week range
0.73
0.90
Trading at 54% of the 52-week range
Market Cap
345.11M
P/E Ratio
41.00
Forward P/E
22.47
Book Value
0.22
Div. Yield
1.95%
% Institutions
65.75%
% Insiders
20.94%

1 Year

-8.5%

3 Year

+35.1%

10 Year

-17.9%
Description

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Company Information

Company Name
Circassia Group Plc
Sector
Healthcare
Industry
Medical Devices
Exchange
OTCGREY
Currency: USD
Full Time Employees: 97
Phone: 44 3303 309 356
Website: niox.com
Fiscal Year End: December
Description:

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Address:

Magdalen Centre, Oxford, United Kingdom, OX4 4GA

People

Directors & Officers

Name Title Year Born
Mr. Jonathan Charles Emms CEO & Executive Director 1963
Ms. Sarah Elizabeth Duncan CFO & Director 1991
Ms. Jodie Driver Global Director of Human Resources NA
Mr. Tom Scaccia Senior Vice President of Americas & Research Business NA
Ms. Rebecca Mary Clayton-Wherity Group Operating FD & Company Secretary NA

Financial Highlights

Market Cap: $345.11M
EBITDA: $14.30M
P/E Ratio: $41.00
Book Value: $0.22
Dividend/Share: $0.02
Dividend Yield: 1.95%
Earnings/Share: $0.02
Profit Margin: 14.37%
Operating Margin: 20.85%
ROA (TTM): 9.25%
ROE (TTM): 11.02%
Revenue (TTM): $48.70M
Revenue/Share (TTM): $0.12
Earnings Growth (YOY): 43.30%
Revenue Growth (YOY): 20.00%

Valuation Metrics

Enterprise Value: $355.23M
Trailing P/E: 41.00
Forward P/E: 22.47

Shares Statistics

Shares Outstanding: 420.87M
Shares Float: 329.29M
% Insiders: 20.94%
% Institutions: 65.75%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$48.70M
Cost of Goods Sold
adjust
$-15.00M
Gross Profit
subtotal
$33.70M
SG&A
adjust
$-20.40M
R&D
adjust
$-2.60M
Other Operating Expense
adjust
$-15.00M
Operating Income
subtotal
$10.70M
Other / Non-Operating Items
adjust
$-3.70M
Net Income
subtotal
$7.00M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CSSPF.US!